IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Accounts Payable of $4.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$11.82M, a 1423.40% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $15.89M, a 674.27% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$5.21M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$4.39M, a 130.43% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$6.66M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was -$7.84M, a 262.41% decline from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was $4.83M, a 17.93% decline from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $5.88M, a 15.67% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 63 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.07M 10-Q · filed 2026-08-06 | -$1.14M derived: sum of 3 quarters · filed 2026-08-06 | -$5.54M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $15.89M 10-Q · filed 2026-05-07 | $10.68M derived: sum of 2 quarters · filed 2026-05-07 | $6.28M derived: sum of 3 quarters · filed 2026-05-07 | $7.17M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$9.61M derived: sum of 2 quarters · filed 2026-02-24 | -$8.71M derived: sum of 3 quarters · filed 2026-08-06 | -$6.66M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | -$4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.50M derived: sum of 2 quarters · filed 2026-08-06 | -$1.45M 10-Q · filed 2025-11-06 | -$7.52M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $893.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.94M 10-Q · filed 2026-08-06 | -$3.13M derived: sum of 3 quarters · filed 2026-08-06 | $11.31M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.05M 10-Q · filed 2026-05-07 | -$4.02M derived: sum of 2 quarters · filed 2026-05-07 | $10.42M derived: sum of 3 quarters · filed 2026-05-07 | $26.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$6.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.36M derived: sum of 2 quarters · filed 2026-02-24 | -$2.03M derived: sum of 3 quarters · filed 2026-02-24 | -$7.84M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $14.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.05M derived: sum of 2 quarters · filed 2025-11-06 | -$1.77M 10-Q · filed 2025-11-06 | $9.65M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | -$10.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$16.20M 10-Q · filed 2025-08-07 | -$4.78M derived: sum of 3 quarters · filed 2026-02-24 | -$14.55M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | -$5.82M 10-Q · filed 2025-05-08 | $5.61M derived: sum of 2 quarters · filed 2026-02-24 | -$4.16M derived: sum of 3 quarters · filed 2026-02-24 | -$4.01M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $11.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.66M derived: sum of 2 quarters · filed 2026-02-24 | $1.80M derived: sum of 3 quarters · filed 2026-02-24 | $4.83M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | -$9.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$9.62M derived: sum of 2 quarters · filed 2024-11-07 | -$6.59M 10-Q · filed 2024-11-07 | -$5.04M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.17M 10-Q · filed 2024-08-08 | $4.73M derived: sum of 3 quarters · filed 2025-02-27 | $8.99M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $3.02M 10-Q · filed 2024-05-09 | $4.58M derived: sum of 2 quarters · filed 2025-02-27 | $8.84M derived: sum of 3 quarters · filed 2025-02-27 | $11.01M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.82M derived: sum of 2 quarters · filed 2025-02-27 | $7.99M derived: sum of 3 quarters · filed 2025-02-27 | $5.88M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $6.43M derived: sum of 2 quarters · filed 2023-11-07 | $4.33M 10-Q · filed 2023-11-07 | $12.04M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $65.00K 10-Q · filed 2023-08-08 | $7.78M derived: sum of 3 quarters · filed 2024-02-28 | $2.09M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | -$2.10M 10-Q · filed 2023-05-10 | $5.61M derived: sum of 2 quarters · filed 2024-02-28 | -$78.00K derived: sum of 3 quarters · filed 2024-02-28 | $4.89M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.03M derived: sum of 2 quarters · filed 2024-02-28 | $6.99M derived: sum of 3 quarters · filed 2024-02-28 | $6.98M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$5.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$725.00K derived: sum of 2 quarters · filed 2022-11-03 | -$740.00K 10-Q · filed 2022-11-03 | -$12.87M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.95M 10-Q · filed 2022-08-04 | -$7.18M derived: sum of 3 quarters · filed 2023-02-28 | $9.08M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$15.00K 10-Q · filed 2022-05-05 | -$12.15M derived: sum of 2 quarters · filed 2023-02-28 | $4.12M derived: sum of 3 quarters · filed 2023-02-28 | $4.79M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$12.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.13M derived: sum of 2 quarters · filed 2023-02-28 | $4.80M derived: sum of 3 quarters · filed 2023-02-28 | -$2.96M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $16.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $16.94M derived: sum of 2 quarters · filed 2021-11-04 | $9.17M 10-Q · filed 2021-11-04 | $15.25M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-30 | $672.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$7.10M 10-Q · filed 2021-08-05 | -$1.01M derived: sum of 3 quarters · filed 2022-02-24 | -$4.34M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-31 | -$7.77M 10-Q · filed 2021-05-06 | -$1.69M derived: sum of 2 quarters · filed 2022-02-24 | -$5.01M derived: sum of 3 quarters · filed 2022-02-24 | $355.00K derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.75M derived: sum of 2 quarters · filed 2022-02-24 | $8.12M derived: sum of 3 quarters · filed 2022-02-24 | $12.71M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.04M derived: sum of 2 quarters · filed 2020-11-05 | $6.63M 10-Q · filed 2020-11-05 | $3.35M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $9.95M 10-Q · filed 2020-08-06 | $6.68M derived: sum of 3 quarters · filed 2021-02-25 | $7.77M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $4.58M 10-Q · filed 2020-05-05 | $4.58M 10-Q · filed 2019-05-07 | $1.31M derived: sum of 2 quarters · filed 2021-02-25 | $2.40M derived: sum of 3 quarters · filed 2021-02-25 | $851.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.18M derived: sum of 2 quarters · filed 2021-02-25 | -$3.73M derived: sum of 3 quarters · filed 2021-02-25 | $1.51M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$457.00K derived: sum of 2 quarters · filed 2019-11-04 | $4.78M 10-Q · filed 2019-11-04 | $3.00M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $3.69M 10-Q · filed 2019-08-01 | $1.91M derived: sum of 3 quarters · filed 2020-02-25 | $1.07M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $5.24M 10-Q · filed 2019-05-07 | $3.46M derived: sum of 2 quarters · filed 2020-02-25 | $2.62M derived: sum of 3 quarters · filed 2020-02-25 | $4.14M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.62M derived: sum of 2 quarters · filed 2020-02-25 | -$1.10M derived: sum of 3 quarters · filed 2020-02-25 | $369.00K 10-K · filed 2020-02-25 | ||
| 2017-09-30 | -$839.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $682.00K derived: sum of 2 quarters · filed 2018-11-06 | $2.15M 10-Q · filed 2018-11-06 | $2.63M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.99M 10-Q · filed 2018-08-07 | $3.47M derived: sum of 3 quarters · filed 2019-02-28 | $2.97M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-03-31 | $1.47M 10-Q · filed 2018-05-10 | $1.95M derived: sum of 2 quarters · filed 2019-02-28 | $1.45M derived: sum of 3 quarters · filed 2019-02-28 | $1.12M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$17.00K derived: sum of 2 quarters · filed 2019-02-28 | -$346.00K derived: sum of 3 quarters · filed 2019-02-28 | -$250.00K 10-K · filed 2019-02-28 | ||
| 2016-09-30 | -$497.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$826.00K derived: sum of 2 quarters · filed 2017-11-02 | -$730.00K 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | -$329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$233.00K 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | $96.00K 10-Q · filed 2017-05-03 | |||||
| 2015-12-31 | -$290.00K 10-K · filed 2018-03-12 | |||||
| 2012-12-31 | $908.22K 10-K · filed 2013-09-23 | $1.10M 10-K · filed 2013-09-23 | ||||
| 2011-12-31 | $159.76K 10-K · filed 2013-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |